
zzso beta zzso administered zzso is zzso in some patients with multiple sclerosis zzso and leads to the development of zzso zzso zzso zzso evidence has accumulated that zzso diminish or abolish zzso zzso but there is less evidence that zzso impact clinical efficacy of the zzso 

Because a robust effect of zzso is a decrease in enhancing zzso on brain zzso scans, the zzso zzso in Multiple zzso With zzso zzso and zzso zzso zzso zzso study, a head-to-head study of zzso vs zzso zzso with a primary zzso of enhancing zzso on zzso provided an excellent opportunity to determine the effect of zzso on zzso zzso We measured zzso and zzso zzso by zzso resistance protein A gene expression and identified 2 groups of zzso one labeled zzso zzso with absent zzso and robust zzso zzso zzso zzso zzso and the other labeled zzso zzso with high levels of zzso and diminished zzso zzso zzso zzso The development of enhancing zzso in the groups was then zzso 

The zzso of zzso and effect of zzso on zzso were consistent with previous zzso We analyzed zzso outcomes in patients with zzso at levels high enough to abolish zzso relative to patients without zzso For the preserved zzso group, the enhancing zzso ratio decreased from zzso in the zzso period to zzso in the zzso period, a zzso zzso For the lost zzso group, the decrease was zzso to zzso only a zzso zzso Thus, lost zzso from high levels of zzso resulted in reduced therapeutic efficacy of zzso as zzso by diminished reductions in enhancing zzso on zzso 

High levels of zzso beta zzso zzso which result in diminished zzso are correlated with reduced therapeutic efficacy of zzso 

